関連する実験動画
Updated: Jul 24, 2026

14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
まとめ
fosforylcholine (PC) 結合抗体のユニークなPhe-Tyr-Met-Glu配列は,PC結合を特異的に阻害するものではありません. 関連ペプチドはまた,非特異的な結合を示し,その提案された役割に挑戦しました.
科学分野:
- 免疫学 免疫学とは
- 構造生物学 構造生物学とは
- バイオケミストリー バイオケミストリー
背景:
- テトラペプチド配列のPhe-Tyr-Met-Gluは,フォスフォリコルリン (PC) 結合抗体の第1補完性決定領域 (CDR1) で高度に保存されています.
- この配列は,抗PCミエロマおよびハイブリドームタンパク質の89%で発見され,PC結合における特定の役割を示唆しています.
研究 の 目的:
- 特定の抗体に対するPC結合を阻害するPhe-Tyr-Met-Glu配列および関連するペプチドの結合効果を調査する.
- McPC603抗体の結合部位を模倣するように設計された表面シミュレーションペプチドを評価するために.
主な方法:
- McPC603およびHOPC8タンパク質へのPC結合のペプチド阻害の比較分析.
- 表面シミュレーションペプチドの構造ミミクリを評価するためのコンピュータモデリング.
主要な成果:
- Phe-Tyr-Met-Glu配列と構造的に関連するペプチドは,PC結合の非特異的阻害を示した.
- コンピューターモデリングは,表面シミュレーションペプチドがMcPC603抗体の結合部位を正確に複製していないことを示しました.
結論:
- 保存されたPhe-Tyr-Met-Gluテトラペプチド配列は,特定のフォスフォリルコリン結合にのみ責任を負うわけではないかもしれません.
- 表面シミュレーションペプチドを含むテストされたペプチドは,非特異的結合を示し,抗体と抗原の相互作用を模倣する際の有用性を疑問視しています.
関連する概念動画
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

